Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.62 USD | +1.29% | +3.36% | -23.31% |
May. 23 | Transcript : Theravance Biopharma, Inc. - Special Call | |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
Financials (USD)
Sales 2024 * | 78.81M | Sales 2025 * | 101M | Capitalization | 419M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | 1M | EV / Sales 2024 * | 4.14 x |
Net cash position 2024 * | 93M | Net cash position 2025 * | - | EV / Sales 2025 * | 4.17 x |
P/E ratio 2024 * |
-20.3
x | P/E ratio 2025 * |
41.5
x | Employees | 99 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.45% |
Latest transcript on Theravance Biopharma, Inc.
1 day | +1.29% | ||
1 week | +3.36% | ||
1 month | -8.00% | ||
3 months | -8.69% | ||
6 months | -19.06% | ||
Current year | -23.31% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 14-05-31 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 14-05-31 |
Eran Broshy
BRD | Director/Board Member | 65 | 14-06-01 |
Director/Board Member | 59 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.03% | 746 M€ | -.--% | - | |
0.02% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.62 | +1.53% | 347,486 |
24-05-30 | 8.49 | +2.41% | 232,484 |
24-05-29 | 8.29 | -1.43% | 348,414 |
24-05-28 | 8.41 | +0.84% | 505,226 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.31% | 419M | |
+40.73% | 739B | |
+31.84% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.89% | 240B | |
+9.44% | 210B | |
-4.99% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- TBPH Stock